Skip to main content
. 2021 Aug 5;17(8):e1009834. doi: 10.1371/journal.ppat.1009834

Fig 2. EBNA2 downregulates the expression of HLA-II.

Fig 2

(A-B) EREB2.5 cells were treated with (+) or without (-) estradiol (E2) for 24 or 48 hrs and then assayed by Western blot for EBNA2 or loading control β-actin (A), and by RT-qPCR for HLA-DRA, -DRB1, -DPA1, -DPB1, or HES1 and c-Myc expression relative to GUSB (B). (C-D) Akata T1 or T2 cells were treated with (+) or without (-) estradiol (E2) for 24, 48 or 72 hrs and then assayed by Western blot for EBNA2 or loading control β-actin (C) or RT-qPCR for HLA-DRA, -DRB1, -DPA1, -DPB1, or HES1 expression relative to GUSB (D). Error bars are standard deviation from mean (SDM) and ** p<0.01, *** p <0.001 using 2-tailed student t-test.